Recombinant Human SLC6A5 Prote
in (N-GST & C-His Tag), 重组人SLC6A5蛋白 (N端GST标签 & C端His标签)- ￥1868
- abinScience
- France
- HA595012
- 2026年03月03日
企业认证
相关产品推荐更多 >
Research Grade Cizutamig, 研究级Cizutamig
￥3428
Recombinant Human CXCL10/IP-10 Protein (N-GST & C-His Tag), 重组人CXCL10/IP-10蛋白 (N端GST标签 & C端His标签)
询价
Recombinant Human GPR143 Protein (N-His-KSI Tag), 重组人GPR143蛋白 (N端His-KSI标签)
￥1868Recombinant Human CARNS1 Protein (N-His Tag), 重组人CARNS1蛋白 (N端His标签)
询价
Research Grade ipsoprubart, 研究级ipsoprubart
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.
- 保质期：
1 year
- 英文名：
Recombinant Human SLC6A5 Protein, N-GST & C-His
- 库存：
999
- 供应商：
abinScience
- 规格：
100ug
| Product name | Recombinant Human SLC6A5 Protein, N-GST & C-His |
|---|---|
| Catalog No. | HA595012 |
| Form | Lyophilized |
| Storage buffer | Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol. |
| Purity | >90% as determined by SDS-PAGE. |
| Applications | ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| Endotoxin level | Please contact with the lab for this information. |
| Expression system | E. coli |
| Accession | Q9Y345 |
| Reconstitution | Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details. |
| Alternative Names | Sodium- and chloride-dependent glycine transporter 2; GlyT-2; GlyT2; Solute carrier family 6 member 5; SLC6A5; GLYT2; NET1 |
| Species | Homo sapiens (Human) |
| Shipping | In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise. |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003...
Product categories and application fields.
Main products...
Application field: Infectious disease research, Neuroscience, Immunology, Oncology
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验• A glycine transporter SLC6A5 frameshift mutation causes startle disease in Spanish greyhounds., PMID:30847549
• Myoclonus., PMID:24092290
• Startles, Stiffness, and SLC6A5: Do You Know the Condition?, PMID:29478738
• SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population., PMID:34797406
• Association Study of the SLC1A2 (rs4354668), SLC6A9 (rs2486001), and SLC6A5 (rs2000959) Polymorphisms in Major Depressive Disorder., PMID:36233781
• Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease., PMID:22700964
• Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease., PMID:16751771
• A frameshift variant in the SLC6A5 gene is associated with startle disease in a family of Old English Sheepdogs., PMID:40012122
Thrombin Cleavage of GST-Fusion protein
activity keeps the enzyme in aliquots at -80°C. Thrombin (MW 37kDa) ~4500units/mg. One unit cleaves theoretical 100ug protein in 16hr at 22°C in buffer. Another possibility is to use high purity enzyme from Sigma # T-6884: 3-10 U of thrombin can be used
Small Scale GST-Tag Purification Under Nature Conditions
Small Scale GST-Tag Purification Under Nature Conditions According to AMERSHAM-BIOSCIENCES-GST fusion protein Handbook (pdf) Aliquot of Cell Pellet after Induction The idea is to aliquot cells after induction
High Throughput Production of Recombinant Human Proteins for Crystallography
, to be applied based on specific knowledge of protein families or when the core protocol is unsatisfactory. This scheme has been applied to more than 550 human proteins (>10,000 constructs) and has resulted in the deposition of 112 unique structures
技术资料暂无技术资料 索取技术资料
